BioNTech Comirnaty Royalty Settlement
This is a news story, published by Yahoo Finance, that relates primarily to Terence Flynn news.
Terence Flynn news
For more Terence Flynn news, you can click here:
more Terence Flynn newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
future royalties. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest latest stocks news, top Wall Street analysts news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Analyst Top StocksTipRanks
•NIH settlement ‘manageable headwind’ for BioNTech, Pfizer, says Morgan Stanley
84% Informative
Morgan Stanley analyst Terence Flynn notes that BioNTech ( BNTX ) announced last week that it had reached a settlement agreement with the National Institutes of Health and University of Pennsylvania regarding past and future royalties on the company and partner Pfizer’s ( PFE ) COVID vaccine, Comirnaty .
Morgan Stanley views this as “a manageable headwind for both companies”.
VR Score
75
Informative language
69
Neutral language
87
Article tone
formal
Language
English
Language complexity
78
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
9
Source diversity
3
Affiliate links
no affiliate links